QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
TSE:MBX

Microbix Biosystems - MBX Stock Forecast, Price & News

C$0.36
-0.01 (-2.70%)
(As of 03/24/2023 05:20 PM ET)
Add
Compare
Today's Range
C$0.36
▼
C$0.36
50-Day Range
C$0.30
▼
C$0.40
52-Week Range
C$0.30
▼
C$0.69
Volume
5,500 shs
Average Volume
52,617 shs
Market Capitalization
C$49.84 million
P/E Ratio
34.00
Dividend Yield
N/A
Price Target
N/A

MBX stock logo

About Microbix Biosystems (TSE:MBX) Stock

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably test ingredients for immunoassays and quality assessment and proficiency testing controls (QAPs) that support sample collection devices. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to test for pathogens and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada.

Receive MBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Microbix Biosystems and its competitors with MarketBeat's FREE daily newsletter.

MBX Stock News Headlines

March 20, 2023 | finance.yahoo.com
Governments of Ontario and Canada Invest in Microbix
March 1, 2023 | finance.yahoo.com
Microbix Supporting Australian Point-of-Care Testing Program
March 24, 2023 | Weiss Ratings (Ad)
Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
February 11, 2023 | finance.yahoo.com
Microbix Biosystems First Quarter 2023 Earnings: Revenues Miss Expectations
February 9, 2023 | finanznachrichten.de
Microbix Biosystems Inc.: Microbix Reports Results for Q1 Fiscal 2023 Sales of $2.5 million, Net Loss of $1.3 million
February 9, 2023 | finance.yahoo.com
Microbix Reports Results for Q1 Fiscal 2023 Sales of $2.5 million, Net Loss of $1.3 million
February 9, 2023 | finance.yahoo.com
Microbix Reports Results for Q1 Fiscal 2023 Sales of $2.5 million, Net Loss of $1.3 million
February 6, 2023 | finance.yahoo.com
Microbix Presenting Results of Collaboration with Health PEI
March 24, 2023 | Weiss Ratings (Ad)
Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
January 30, 2023 | finance.yahoo.com
Microbix Launches QAP to Support “Monkeypox” Testing
December 27, 2022 | finance.yahoo.com
Analysts Just Slashed Their Microbix Biosystems Inc. (TSE:MBX) EPS Numbers
December 23, 2022 | finance.yahoo.com
Microbix Biosystems Inc. (TSE:MBX) Not Lagging Market On Growth Or Pricing
December 22, 2022 | finance.yahoo.com
Microbix Reports Record Sales for Fiscal 2022
October 6, 2022 | finance.yahoo.com
Microbix Presenting Test-Workflow Validation Results at EMMD
October 6, 2022 | finance.yahoo.com
Is Microbix Biosystems Inc.'s (TSE:MBX) Latest Stock Performance Being Led By Its Strong Fundamentals?
September 28, 2022 | finance.yahoo.com
Microbix Announces Initiation of Normal Course Issuer Bid
September 20, 2022 | reuters.com
Microbix Biosystems Inc
August 11, 2022 | finance.yahoo.com
Microbix Reports Results for Q3 Fiscal 2022
August 10, 2022 | finance.yahoo.com
Microbix Executes Substantial QAPs Supply Agreement
August 5, 2022 | finance.yahoo.com
Investors in Microbix Biosystems (TSE:MBX) have made a splendid return of 104% over the past three years
May 31, 2022 | finance.yahoo.com
Is Microbix Biosystems (TSE:MBX) Using Too Much Debt?
May 12, 2022 | finance.yahoo.com
Microbix Reports Record Results for Q2 Fiscal 2022
April 29, 2022 | finance.yahoo.com
Microbix Biosystems Inc. (TSE:MBX) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
April 28, 2022 | finance.yahoo.com
Microbix Presenting at the 2022 Bloom Burton Conference
April 19, 2022 | finance.yahoo.com
Microbix Presenting Respiratory Virus Controls Data at Two Events
April 8, 2022 | finance.yahoo.com
Microbix Presenting HPV Product Results at EUROGIN
March 29, 2022 | finance.yahoo.com
Microbix Invests to Further Scale Its Business
See More Headlines
Receive MBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Microbix Biosystems and its competitors with MarketBeat's FREE daily newsletter.

MBX Company Calendar

Last Earnings
2/09/2023
Today
3/24/2023
Next Earnings (Estimated)
5/11/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
TSE:MBX
CUSIP
N/A
CIK
N/A
Web
microbix.com
Phone
+1-905-3618910
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
34.00
Forward P/E Ratio
38.06
P/E Growth
N/A
Net Income
N/A
Net Margins
-2.34%
Pretax Margin
N/A
Return on Equity
-1.71%
Return on Assets
0.56%

Debt

Debt-to-Equity Ratio
25.43
Current Ratio
6.32
Quick Ratio
5.57

Sales & Book Value

Annual Sales
C$16.72 million
Price / Sales
3.06
Cash Flow
C$0.09 per share
Price / Cash Flow
4.13
Book Value
C$0.17 per share
Price / Book
2.18

Miscellaneous

Outstanding Shares
138,450,000
Free Float
N/A
Market Cap
C$51.23 million
Optionable
Not Optionable
Beta
0.16

Key Executives

  • Mr. Cameron L. Groome
    Pres, CEO & Director
  • Mr. James S. Currie
    Chief Financial Officer
  • Dr. Kenneth Hughes Ph.D.
    Chief Operating Officer
  • Dr. Mark Luscher Ph.D.
    Sr. VP of Scientific Affairs
  • Mr. Philip Casselli
    Sr. VP of Sales, Bus. Devel. & Marketing
  • Mr. Christopher B. Lobb
    Compliance Officer, Gen. Counsel & Sec.

Key Competitors

View All Competitors

Insiders

View All Insider Transactions













MBX Stock - Frequently Asked Questions

Should I buy or sell Microbix Biosystems stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Microbix Biosystems in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MBX shares.
View MBX analyst ratings or view top-rated stocks.

How have MBX shares performed in 2023?

Microbix Biosystems' stock was trading at C$0.41 at the start of the year. Since then, MBX stock has decreased by 9.8% and is now trading at C$0.37.
View the best growth stocks for 2023 here.

When is Microbix Biosystems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 11th 2023.
View our MBX earnings forecast.

How were Microbix Biosystems' earnings last quarter?

Microbix Biosystems Inc. (TSE:MBX) announced its quarterly earnings results on Thursday, February, 9th. The company reported ($0.01) EPS for the quarter, hitting analysts' consensus estimates of ($0.01). The business earned $2.50 million during the quarter, compared to the consensus estimate of $2.80 million. Microbix Biosystems had a negative trailing twelve-month return on equity of 1.71% and a negative net margin of 2.34%.

What other stocks do shareholders of Microbix Biosystems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Microbix Biosystems investors own include TransAlta Renewables (RNW), Organigram (OGI), Dynavax Technologies (DVAX), Heat Biologics (HTBX), VEON (VEON), Vaxart (VXRT), Wajax (WJX), BlackBerry (BB) and Canadian Western Bank (CWB).

What is Microbix Biosystems' stock symbol?

Microbix Biosystems trades on the Toronto Stock Exchange (TSX) under the ticker symbol "MBX."

How do I buy shares of Microbix Biosystems?

Shares of MBX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Microbix Biosystems' stock price today?

One share of MBX stock can currently be purchased for approximately C$0.37.

How much money does Microbix Biosystems make?

Microbix Biosystems (TSE:MBX) has a market capitalization of C$51.23 million and generates C$16.72 million in revenue each year.

How can I contact Microbix Biosystems?

Microbix Biosystems' mailing address is 265 Watline Ave, MISSISSAUGA, ON L4Z 1P3, Canada. The official website for the company is microbix.com. The company can be reached via phone at +1-905-3618910.

This page (TSE:MBX) was last updated on 3/24/2023 by MarketBeat.com Staff